Company Filing History:
Years Active: 2018-2021
Title: Carol O'Brien: Innovator in Cancer Treatment
Introduction
Carol O'Brien is a notable inventor based in Pacifica, CA, who has made significant contributions to the field of cancer treatment. With two patents to her name, she has focused her research on genetic variations associated with drug resistance, particularly in relation to anti-mitotic agents.
Latest Patents
Her latest patents include methods and compositions that determine if a cancer is resistant to treatment with anti-mitotic agents, including T-DM1. These methods specifically relate to assessing whether the ABCC3 gene is amplified and/or overexpressed in the cancer, providing valuable insights for treatment strategies.
Career Highlights
Carol O'Brien is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. Her work has been instrumental in advancing the understanding of cancer resistance mechanisms.
Collaborations
Some of her notable coworkers include Mark Lackner and Lukas C Amler, who have collaborated with her on various projects aimed at improving cancer treatment outcomes.
Conclusion
Carol O'Brien's contributions to cancer research and her innovative patents highlight her role as a key figure in the fight against cancer. Her work continues to pave the way for advancements in treatment methodologies.